|
Volumn 347, Issue 4, 2002, Pages 248-255
|
Kidney transplantation from donors without a heartbeat
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN;
CYCLOSPORIN A;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
THYMOCYTE ANTIBODY;
ADULT;
AGE;
AGED;
ARTICLE;
CADAVER KIDNEY;
CHRONOBIOLOGY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
FOLLOW UP;
FUNCTIONAL ANATOMY;
GENDER;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART BEAT;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
INCIDENCE;
KIDNEY DONOR;
KIDNEY TRANSPLANTATION;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
MALE;
ORGAN DONOR;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL ANALYSIS;
SURGICAL RISK;
SURVIVAL TIME;
SWITZERLAND;
EMPIRICAL APPROACH;
HEALTH CARE AND PUBLIC HEALTH;
PROFESSIONAL PATIENT RELATIONSHIP;
ADULT;
ANALYSIS OF VARIANCE;
BRAIN DEATH;
CADAVER;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT SURVIVAL;
HEART ARREST;
HUMANS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
OUTCOME ASSESSMENT (HEALTH CARE);
RISK FACTORS;
SURVIVAL ANALYSIS;
TISSUE DONORS;
|
EID: 0037173461
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMoa020274 Document Type: Article |
Times cited : (327)
|
References (29)
|